Diane D. Liu - Concepedia

Author

Diane D. Liu

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

DIANE D. LIU, Diane D Liu, Diane D. Liu, Diane Liu

420

Publications

7.4K

Citations

H-Index

117

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine

About

Diane D. Liu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	1.5K
2	Health Sciences	7	7	216
3	Nursing	5	5	96
4	Engineering	2	2	52
5	Natural Sciences	1	1	141

Diane D. Liu

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang, Clinical Cancer Research	2007	598
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer Roy S. Herbst, David H. Johnson, Eric D. Mininberg, Journal of Clinical Oncology	2005	535
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Jean‐Charles Soria, Ho‐Young Lee, Janet I. Lee, PubMed	2002	409
Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer Stéphane Temam, Hidetoshi Kawaguchi, Adel K. El‐Naggar, Journal of Clinical Oncology	2007	399
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Ping Yuan, Stéphane Temam, Adel K. El‐Naggar, Cancer	2006	304
ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Mohamed Kabbout, Melinda Garcia, Junya Fujimoto, Clinical Cancer Research	2013	190
A predictive probability design for phase II cancer clinical trials J. Jack Lee, Diane D. Liu Clinical Trials	2008	179
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting <i>Flt1/VEGFR1</i> Jonathon D. Roybal, Yi Zang, Young‐Ho Ahn, Molecular Cancer Research	2010	174
Response to Neoadjuvant Systemic Therapy for Breast Cancer in <i>BRCA</i> Mutation Carriers and Noncarriers: A Single-Institution Experience Banu Arun, Soley Bayraktar, Diane D. Liu, Journal of Clinical Oncology	2011	170
Low locoregional failure rates in selected breast cancer patients with tumor‐positive sentinel lymph nodes who do not undergo completion axillary dissection Rosa F. Hwang, Ana M. Gonzalez‐Angulo, Min Yi, Cancer	2007	156

Page 1